ThinkstockOver the past month, interest rates have bounced off of their 2013 lows, with the U.S. 10-year yield quickly rising from 1.66% to more than 2.20%. This has been a negative for…
ThinkstockMuch of the research coverage on Wall St. from the bulge bracket firms is concentrated on the most liquid, best known stocks from the S&P 500. These names are recognizable to investors…
U.S. medical instruments and supplies maker Baxter International Inc. (NYSE: BAX) said this morning that it has signed a definitive agreement to acquire privately held Swedish dialysis product firm Gambro AB for…
Paul Ausick US equity markets opened sharply higher this morning and have been able to sustain and even add to those gains throughout the day. Business and consumer confidence indexes in Europe were higher,…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage research calls this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) Added to Strong Buy List at Zacks…
Share repurchase programs, or stock buybacks, have been and may always be a more questionable method of returning capital to shareholders than dividends. Many even disagree with the effect of buybacks. Still,…
These are this Tuesday morning’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Baxter International (NYSE: BAX) Cut to Hold at Citigroup. CIENA Corporation (NASDAQ: CIEN) Raised to…
Updated throughout the day. Update: RADVision (RVSN) is trading down over 33% on rumors that the Cisco (CSCO) buyout of Tandberg will cost it nearly 40% of its revenue. (Morgan Keegan) Update: Friday’s…
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest data suggest traders are now…
These are the top big analyst calls from Wall Street we have seen very early this Friday morning with over two and a half hours until the market opens: Baidu (BIDU) Started…
Baxter (NYSE: BAX) is probably retaining more lawyers. So far nineteen people have died from tainted Heparin, a blood-thinner. BAX is one of the largest marketers of the drug. According to The…
Douglas A. McIntyre Amicus Therapeutics (NASDAQ: FOLD) had a late afternoon surge, up 7% to $10.73. The 52 week range is $9.00 to $18.22. Baxter International (NYSE: BAX)—contaminant in recalled Heparin identified by the FDA…
According to Reuters, Toshiba will drop its HD DVD format. Reuters reports that Blll Gates said Microsoft (MSFT) will target web search with or without Yahoo! (YHOO) Reuters writes that RIM (RIMM)…
The uproar about Heparin, a widely-used drug marketed by Baxter International (NYSE: BAX), is just beginning. As The Wall Street Journal writes "Baxter said the active ingredient for its heparin was supplied…
Douglas A. McIntyre According to Reuters, Citigroup says UBS (UBS) may face another $18 billion in write-downs this year. Reuters writes that Alan Greenspan says the US is on the edge of recession. Reuters writes…
